| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 16, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 17.5 | -13,826 | -3.61% | ✗ | $1M |
| Nov 16, 2025 | Nov 18, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 23.8 | -38,251 | -9.08% | ✓ | $2.5M |
| Aug 21, 2025 | Aug 22, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 17.5 | -42,237 | -9.12% | ✗ | $2.1M |
| Aug 16, 2025 | Aug 19, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 23.8 | -38,670 | -7.70% | ✓ | $2M |
| May 16, 2025 | May 20, 2025 | BridgeBio Pharma, Inc. | CFO | Sell | 20.0 | -21,317 | -4.07% | ✗ | $721.4K |
| Feb 16, 2025 | Feb 19, 2025 | BridgeBio Pharma, Inc. | COO | Sell | 20.0 | -13,782 | -3.22% | ✗ | $481K |
| Nov 16, 2024 | Nov 19, 2024 | BridgeBio Pharma, Inc. | COO | Sell | 20.0 | -17,936 | -4.53% | ✗ | $425.4K |
| Aug 16, 2024 | Aug 20, 2024 | BridgeBio Pharma, Inc. | COO | Sell | 20.0 | -17,936 | -4.33% | ✗ | $437.6K |